Welcome to romema

Welcome to romema

Phase II study with the PDE-4 inhibitor roflumilast in patients with mild cognitive impairment (MCI)
Welcome to the ROMEMA website! On this website you will find more information about the clinical trial "ROMEMA". See below and click on the different icons in case you are interested in the project.
ROMEMA
Roflumilast
Collaborations
Contact